Purchase Order 75N98026P01418

The National Institutes of Health Clinical Center awarded a $18,000 firm fixed-price purchase order to Phadia US Inc.'s Immunodiagnostics Division for allergen-specific immunoglobulin E (IGE) testing services. The contract, awarded on April 30, 2026, with completion by April 29, 2027, covers testing of 600 frozen serum and plasma biospecimens at $30 per test. Performance will be conducted at Phadia's facility in Portage, Michigan. This procurement was conducted using open market procedures...

<p>The NIH Clinical Center awarded a purchase order to Euroimmun US Incorporated on July 21, 2017, with a ceiling value of $24,501.40 and an ultimate completion date of August 21, 2017. The order is firm fixed price with no small business set-aside. Place of performance is Bethesda, Maryland. The source does not specify the detailed scope of goods or services procured under this purchase order.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Euroimmun US Incorporated on July 12, 2017, for $7,200.00, with a completion date of July 31, 2017. The order is a firm fixed-price commercial purchase with no set-aside designation. Place of performance is Bethesda, Maryland. The source does not specify what diagnostic reagents, test kits, or medical supplies are included in the order.</p>

<p>The NIH Clinical Center awarded a purchase order to One Lambda, Inc. valued at $615,447.36 on June 1, 2026, for HLA typing and antibody screening reagents to support the HLA Lab on a regular basis. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of September 30, 2026. No set-aside was used.</p>

<p>The NIH Clinical Center awarded a purchase order to One Lambda, Inc. on April 6, 2026, with a ceiling value of $81,694.31 for HLA typing and antibody screening reagents to support clinical testing at the HLA Lab. Performance is located in West Hills, California, with an ultimate completion date of April 5, 2027. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The Defense Health Agency issued a BPA call to Phadia US Inc. on April 20, 2026, for essential immunodiagnostic items with a ceiling value of $84,782.70. The call procures IMMUNOCAP SPEC IGE-conjugate supplies for lab duties. Work is performed in Portage, Michigan, and is scheduled for completion by September 30, 2026. Pricing is firm fixed price under an open market procurement with no set-aside applied.</p>

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a $35,000.00 Firm Fixed Price Purchase Order to American Laboratory Products Company, LTD dba Alpco Diagnostics for a High Specificity Through Molecular Allergens Automatic Processing System - Allergy Diagnostics Equipment (AMBIS #2231182). This equipment, which includes an ImageXplorer Bundle, Lab Rocker, ConfigXplorer Test Array, Array Holder, Incubation Chamber, Laptop, and...

<p>The Defense Health Agency issued a BPA call to Phadia US Inc. on March 24, 2026, with a ceiling value of $84,852.34 for supplies and services for a medical treatment facility. The call is firm fixed price with an ultimate completion date of September 30, 2026. Performance takes place in Portage, Michigan. The call supports medical diagnostic equipment and related services, consistent with the awardee's specialization in allergy and autoimmune testing solutions. No set-aside was used.</p>

The NIH Clinical Center issued a delivery order to One Lambda, Inc. on August 6, 2020, for various HLS typing and antibody screening reagents, with a ceiling value of $617,196.90. Place of performance is Canoga Park, CA. The order was issued on a firm fixed-price basis with an ultimate completion date of July 31, 2021. The award was made to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Aapharmasyn LLC on June 24, 2026, with a ceiling value of $1,127,656 for interventional agents chemistry services. The order is priced on a cost-plus-fixed-fee basis and concludes on March 23, 2027. Performance occurs in Ann Arbor, MI.</p>